Sean P. Troth, Ph.D.
Affiliations: | 2004 | Colorado State University, Fort Collins, CO |
Area:
Pathology, Microbiology Biology, PharmacologyGoogle:
"Sean Troth"Parents
Sign in to add mentorEdward A. Hoover | grad student | 2004 | Colorado State | |
(CXCR4 in feline immunodeficiency virus infection and an experimental therapy.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vlasakova K, Troth SP, Sistare FD, et al. (2020) Evaluation of 10 Urinary Biomarkers for Renal Safety With 5 Nephrotoxicants in Nonhuman Primates. Toxicologic Pathology. 48: 633-648 |
Troth SP, Vlasakova K, Amur S, et al. (2019) Translational Safety Biomarkers of Kidney Injury. Seminars in Nephrology. 39: 202-214 |
Troth SP, Simutis F, Friedman GS, et al. (2019) Kidney Safety Assessment: Current Practices in Drug Development. Seminars in Nephrology. 39: 120-131 |
Troth SP, Everds NE, Siska W, et al. (2018) Scientific and Regulatory Policy Committee Points to Consider: Data Visualization for Clinical and Anatomic Pathologists. Toxicologic Pathology. 192623318778733 |
Gu YZ, Vlasakova K, Troth SP, et al. (2018) Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs. Toxicologic Pathology. 192623318775023 |
Phillips JA, Holder DJ, Ennulat D, et al. (2016) Rat Urinary Osteopontin and Neutrophil gelatinase-associated lipocalin Improve Certainty of Detecting Drug-Induced Kidney Injury. Toxicological Sciences : An Official Journal of the Society of Toxicology |
Vlasakova K, Erdos Z, Troth SP, et al. (2014) Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies Toxicological Sciences. 138: 3-20 |
Burkhardt JE, Pandher K, Solter PF, et al. (2011) Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies. Toxicologic Pathology. 39: 1129-37 |
Burkhardt JE, Ennulat D, Pandher K, et al. (2010) Topic of histopathology blinding in nonclinical safety biomarker qualification studies. Toxicologic Pathology. 38: 666-7 |
Ozer JS, Dieterle F, Troth S, et al. (2010) A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nature Biotechnology. 28: 486-94 |